Loading company…
Ovagen produces germ-free chicken eggs and birds for pharmaceutical and biomanufacturing applications.
Ovagen produces germ-free chicken eggs and birds for pharmaceutical applications, including vaccine, antibody and therapeutic protein production. Founded in 2000, the company is based in Ireland. In June 2024, it raised EUR 7.81 million in Series A funding led by the Western Development Commission, with participation from Irrus Investments, Boole Investment Syndicate, DeepIE Ventures, Spark Crowdfunding, Halo Business Angel Network, Edensor Commercial Limited and Enterprise Ireland. The funding was intended to increase annual production to four million eggs and expand its workforce.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in